Genetic Variant in Human PAR (Protease-Activated Receptor) 4 Enhances Thrombus Formation Resulting in Resistance to Antiplatelet Therapeutics

Benjamin E. Tourdot(Cincinnati Children's Hospital Medical Center), Michael Holinstat(University of Michigan), Paul F. Bray(University of Southampton), Leonard C. Edelstein, Derek Trumbo, Gregory G. Tall(University of Michigan), Yogendra Kanthi(National Heart Lung and Blood Institute), Jennifer Yeung(Thomas Jefferson University), Hannah M. Stoveken(University of Michigan)
Arteriosclerosis Thrombosis and Vascular Biology
May 10, 2018
Cited by 40


Related Papers